• Info
  • Insider Ownership

Insider Trading & Ownership of DEAN J. MITCHELL

Location
New York, NY
Summary
The estimated net worth of DEAN J. MITCHELL is at least $2,493,524 dollars as of 25 Sep 2025. DEAN J. MITCHELL is the Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $889.2K. DEAN J. MITCHELL is the Director of PRECIGEN, INC. and owns shares of PRECIGEN, INC. (PGEN) stock worth about $844.6K. DEAN J. MITCHELL is the Director of Praxis Precision Medicines, Inc. and owns shares of Praxis Precision Medicines, Inc. (PRAX) stock worth about $759.7K.
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when DEAN J. MITCHELL files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of DEAN J. MITCHELL

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. Director $889,239 19 May 2025
PGEN PRECIGEN, INC. Director $844,551 14 Mar 2024
PRAX Praxis Precision Medicines, Inc. Director $759,734 24 Sep 2025
IMGN ImmunoGen, Inc. Director $0 12 Feb 2024
KNTE Kinnate Biopharma Inc. Director 03 Apr 2024

Insider Transactions Reported by DEAN J. MITCHELL:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.